Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Levofloxacin for SSI Prevention in Emergency Laparotomy
NCT07696819Not yet recruiting
- Sponsor
- Sylhet MAG Osmani Medical College
- Start
- Aug 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Randomised trial of levofloxacin in surgical site infection (SSI) (2 arms), sponsored by Sylhet MAG Osmani Medical College. Primary endpoint: Incidence of Surgical Site Infection at 30 days. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
levofloxacin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07696819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07696819.